[
  {
    "date": "2023-06-29",
    "symbol": "NXEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--06-30",
    "entityfilenumber": "000-55320",
    "entityregistrantname": "NEXIEN BIOPHARMA, INC.",
    "entitycentralindexkey": 1625288,
    "entitytaxidentificationnumber": "26-2049376",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "4340     East Kentucky Avenue",
    "entityaddressaddressline2": "Suite 206",
    "entityaddresscityortown": "Glendale",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80246,
    "cityareacode": "(303)",
    "localphonenumber": "495-7583",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 2738,
    "auditorname": "M&K CPAS, PLLC",
    "auditorlocation": "Houston, TX",
    "cashandcashequivalentsatcarryingvalue": 35147,
    "otherprepaidexpensecurrent": 7980,
    "assetscurrent": 43127,
    "assets": 43127,
    "accountspayableandaccruedliabilitiescurrent": 23643,
    "otherliabilitiescurrent": 45000,
    "convertiblenotespayablecurrent": 56037,
    "liabilitiescurrent": 295134,
    "liabilities": 295134,
    "commonstockvalue": 6402,
    "additionalpaidincapital": 10986201,
    "stockpayable": 50750,
    "retainedearningsaccumulateddeficit": -11295360,
    "stockholdersequity": -252007,
    "liabilitiesandstockholdersequity": 43127,
    "debtinstrumentunamortizeddiscountcurrent": 8963,
    "debtinstrumentunamortizeddiscount": 28274,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 64022196,
    "commonstocksharesoutstanding": 64022196,
    "professionalfees": 35660,
    "generalandadministrativeexpense": 246948,
    "operatingexpenses": 282608,
    "interestexpenseother": 29531,
    "amortizationofdebtdiscountpremium": 49763,
    "othernonoperatingincomeexpense": -79294,
    "netincomeloss": -361902,
    "earningspersharebasic": -0.01,
    "earningspersharediluted": -0.01,
    "weightedaveragenumberofsharesoutstandingbasic": 62333322,
    "weightedaveragenumberofdilutedsharesoutstanding": 62333322,
    "sharesoutstanding": 64022196,
    "stockissuedduringperiodvalueissuedforservices": 300,
    "stockissuedduringperiodsharesissuedforservices": 3000000,
    "adjustmentstoadditionalpaidincapitalimputedinterestonrelatedpartyadvances": 4500,
    "stockissuedduringperiodvalueother": 50,
    "stockissuedduringperiodsharesother": 500000,
    "imputedinterestonrelatedpartyadvances": 4500,
    "stockissuedtoofficersanddirector": 152250,
    "stockissuedtoofficers": 50750,
    "stockissuedtoloanextension": 20000,
    "amortizationoffinancingcostsanddiscountsrelatedparty": 21489,
    "amortizationoffinancingcostsanddiscounts": 28274,
    "increasedecreaseinprepaidexpense": 360,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3248,
    "netcashprovidedbyusedinoperatingactivities": -81751,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -81751,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 35147,
    "stockissued1": 203000,
    "sharesissuedforsettlementofloanextension": 20000,
    "workingcapitaldeficit": 252007,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7995000,
    "stockissuedduringperiodvaluenewissues": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7995000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 5529409,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexerciseprice": 0.0429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2500000,
    "numberofsharesissuedinstockpayable": 750000,
    "stockissuedduringperiodsharesnewissues": 500000,
    "sharesissuedpricepershare": 0.04,
    "commonstockcapitalsharesreservedforfutureissuance": 8000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "the number of shares available for grant and issuanceunder the 2018 Plan will be increased on July 1 of each of the next ten calendar years by the lesser of (a) 15% of the number of sharesissued during the most recently completed fiscal year or (b) such number of shares determined by the board of directors.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 6682730,
    "workingcapital": 45000,
    "receivablewithimputedinteresteffectiveyieldinterestrate": 0.1,
    "receivablewithimputedinterestnetamount": 4500,
    "equitymethodinvestmentownershippercentage": 1,
    "deferredtaxassetsoperatinglosscarryforwards": 688923,
    "deferredtaxassetsvaluationallowance": 688923,
    "effectiveincometaxratecontinuingoperations": 0.24,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.03,
    "increasedecreaseinnetoperatinglossbenefit": -38232,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 38232,
    "operatinglosscarryforwards": 2863000,
    "operatinglosscarryforwardsexpirationdatedescription": "The available net operating loss carry forwards expire in various years through2042. No tax benefit has been reported in the financial statements because the Company believes there is a 50% or greater chance thecarry forwards will expire unused"
  },
  {
    "date": "2022-06-29",
    "symbol": "NXEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "June 30, 2022",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "June 30",
    "entityfilenumber": "000-55320",
    "entityregistrantname": "NEXIENBIOPHARMA, INC.",
    "entitycentralindexkey": 1625288,
    "entitytaxidentificationnumber": "26-2049376",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "4340 East    Kentucky Avenue",
    "entityaddressaddressline2": "Suite 206",
    "entityaddresscityortown": "Glendale",
    "entityaddressstateorprovince": "Colorado",
    "entityaddresspostalzipcode": 80246,
    "cityareacode": 303,
    "localphonenumber": "495-7583",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "No",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 2738,
    "auditorname": "M&K CPAS, PLLC",
    "auditorlocation": "Houston, TX",
    "cash": 116898,
    "otherprepaidexpensecurrent": 7620,
    "assetscurrent": 124518,
    "assets": 124518,
    "accountspayableandaccruedliabilitiescurrent": 20395,
    "duetoofficersorstockholderscurrent": 45000,
    "convertiblenotespayablerelatedparty": 34548,
    "convertiblenotespayablecurrent": 142180,
    "liabilitiescurrent": 242123,
    "liabilities": 242123,
    "commonstockvalue": 6052,
    "additionalpaidincapital": "null",
    "stockpayable": 50750,
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": 124518,
    "debtinstrumentunamortizeddiscountcurrent": 30452,
    "debtinstrumentunamortizeddiscount": 28274,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "professionalfees": 33230,
    "generalandadministrativeexpense": 530762,
    "operatingexpenses": 563992,
    "interestexpenseother": 17945,
    "amortizationofdebtdiscountpremium": 21607,
    "othernonoperatingincomeexpense": -62365,
    "netincomeloss": -626357,
    "earningspersharebasic": -0.01,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvalueissuedforservices": 140000,
    "stockissuedduringperiodsharesissuedforservices": "null",
    "amortizationofacquisitioncosts": 223255,
    "stockissuedduringperiodvaluenewissues": 50750,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalwarrantissued": 110264,
    "stockissuedduringperiodexerciseofwarrantissuedforconsultingservices": 2250,
    "stockissuedduringperiodsharesexerciseofwarrantissuedforconsultingservices": "null",
    "stockissuedduringperiodvalueother": 18558,
    "stockissuedduringperiodsharesother": 500000,
    "adjustmentstoadditionalpaidincapitalwarrantissuedforconvertibledebt": 8825,
    "adjustmentstoadditionalpaidincapitalimputedinterestonrelatedpartyadvances": 3625,
    "sharesissuedpricepershare": 0.07,
    "fairvalueofsharesissuedforacquisition": 223255,
    "fairvalueofwarrantsissued": -110264,
    "imputedinterestonrelatedpartyadvances": 3625,
    "stockissuedtoofficersanddirector": 105000,
    "stockissuabletoofficers": 50750,
    "amortizationoffinancingcostsanddiscountsrelatedparty": 21606,
    "amortizationoffinancingcostsanddiscounts": 22814,
    "increasedecreaseinprepaidexpense": 120,
    "increasedecreaseinaccountspayableandaccruedliabilities": 14020,
    "netcashprovidedbyusedinoperatingactivities": -75143,
    "proceedsfromconvertibledebt": 146750,
    "proceedsfromwarrantexercises": 2250,
    "proceedsfromrelatedpartydebt": 25000,
    "netcashprovidedbyusedinfinancingactivities": 174000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 98857,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 116898,
    "sharesissuedtoofficersforservices": 140000,
    "discountonconvertibledebt": 32633,
    "workingcapital": 25000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 347512,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 3.7,
    "classofwarrantorrightoutstanding": "null",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.075,
    "warrantsandrightsoutstandingmaturitydate": "November 24, 2025",
    "warrantsandrightsoutstandingmeasurementinput": 1.53,
    "warrantsandrightsoutstandingterm": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexerciseprice": 0.0429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsoutstandingweightedaverageremainingcontractualterms": 3.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardotherthanoptionsgrantsinperiodgrantdatefairvalue": 110264,
    "receivablewithimputedinteresteffectiveyieldinterestrate": 0.1,
    "receivablewithimputedinterestnetamount": 3625,
    "accountspayablerelatedpartiescurrent": 15750,
    "equitymethodinvestmentownershippercentage": 1,
    "deferredtaxassetsoperatinglosscarryforwards": 650691,
    "deferredtaxassetsvaluationallowance": 650691,
    "effectiveincometaxratecontinuingoperations": 0.24,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.03,
    "increasedecreaseinnetoperatinglossbenefit": -33370,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 33370,
    "incometaxexaminationdescription": "On December22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted into law and the new legislation contains several key tax provisionsthat affected us, including a reduction of the corporate income tax rate to 21% effective January 1, 2018.",
    "operatinglosscarryforwards": "null",
    "operatinglosscarryforwardsexpirationdatedescription": "The available net operating loss carry forwards expire in various years through2041. No tax benefit has been reported in the financial statements because the Company believes there is a 50% or greater chance thecarry forwards will expire unused."
  },
  {
    "date": "2021-06-29",
    "symbol": "NXEN",
    "period": "FY",
    "entityregistrantname": "NEXIEN BIOPHARMA, INC.",
    "entitycentralindexkey": 1625288,
    "documenttype": "10-K",
    "documentperiodenddate": "2021-06-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "cashandcashequivalentsatcarryingvalue": 18041,
    "prepaidexpensecurrent": 7500,
    "assetscurrent": 25541,
    "assets": 25541,
    "accountspayableandaccruedliabilitiescurrent": 6375,
    "duetoofficersorstockholderscurrent": 20000,
    "convertiblenotespayablecurrent": 12941,
    "liabilitiescurrent": 39316,
    "commonstockvalue": 5577,
    "additionalpaidincapital": 10476004,
    "stockpayable": 35000,
    "commonstocksubjecttoforfeiture": -223255,
    "retainedearningsaccumulateddeficit": -10307101,
    "stockholdersequity": -10307101,
    "liabilitiesandstockholdersequity": 25541,
    "debtinstrumentunamortizeddiscountcurrent": 52059,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 55772196,
    "commonstocksharesoutstanding": 55772196,
    "professionalfees": 43710,
    "generalandadministrativeexpenses": 1800057,
    "operatingexpenses": 1843767,
    "interestexpenserelatedparty": 3234,
    "amortizationofdebtdiscountpremium": 12941,
    "othernonoperatingincomeexpense": -16175,
    "netincomeloss": -1859942,
    "earningspersharebasicanddiluted": -0.03,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 55399643,
    "sharesoutstanding": 55772196,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 24981,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 1797192,
    "stockissuedduringperiodvalueissuanceofstockforaccountspayable": 13485,
    "stockissuedduringperiodsharesissuanceofstockforaccountspayableshares": 150000,
    "stockissuedduringperiodvalueissuedforservices": 35000,
    "stockissuedduringperiodsharesissuedforservices": 250000,
    "amortizationofacquisitioncosts": 1093668,
    "stockissuedduringperiodvalueother": 271025,
    "stockissuedduringperiodsharesother": 2250000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 348953,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 65000,
    "commonstockissuabletoofficers": 35000,
    "stockrepurchasedduringperiodvalue": 1830840,
    "stockrepurchasedduringperiodshares": -2409000,
    "sharesissuedpricepershare": 0.09,
    "sharebasedcompensation": 348953,
    "fairvalueofsharesissuedforcrxacquisition": 1093668,
    "stockissuedtoofficersanddirector": 271250,
    "stockissuabletoofficers": 35000,
    "increasedecreaseinprepaidexpense": -4500,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2885,
    "netcashprovidedbyusedinoperatingactivities": -90745,
    "proceedsfromconvertibledebt": 78000,
    "proceedsfromrelatedpartydebt": 20000,
    "netcashprovidedbyusedinfinancingactivities": 98000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 7255,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 18041,
    "sharesissuedforsettlementofaccountspayable": 13500,
    "stockissued1": 25161,
    "operatingincomeloss": 10307101,
    "workingcapital": 13775,
    "stockissuedduringperiodsharesnewissues": 250000,
    "stockissuedduringperiodvaluenewissues": 78875,
    "legalfees": 94040,
    "capitalizedcostofintangibleassets": 302915,
    "shareprice": 0.014,
    "convertiblenotespayable": 25000,
    "interestpayablecurrent": 161,
    "saleofstockdescriptionoftransaction": "The Board of Directors authorized the issuance of a total of 2,500,000 shares of common stock of the Company to each of its Chief Executive Officer and Chief Financial Officer, with 250,000 of such shares to be issued to each of them every quarter beginning July 1, 2021 and continuing every three months through October 1, 2023, it being the intent of the Board that the issuance of these shares represents compensation for services rendered for the then completed calendar quarter (See Note 8).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 348953,
    "valueofvestedsharesissuedandamortizationofunvestedshares": 4880904,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 5000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7995000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingandexcerisableweightedaverageremainingcontractualterm2": "P4Y6M0D",
    "classofwarrantorrightoutstanding": 1727299,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.045157,
    "warrantsandrightsoutstandingmaturitydate": "2025-11-24",
    "warrantsandrightsoutstandingmeasurementinput": 153,
    "warrantsandrightsoutstandingterm": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 5181897,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 5181897,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexerciseprice": 0.0429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexercisepricegranted": 0.0429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsoutstandingweightedaverageremainingcontractualtermsbeginningbalance": "P4Y4M24D",
    "equitymethodinvestmentownershippercentage": 1,
    "costsandexpenses": 201228,
    "incometaxexaminationdescription": "On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted into law and the new legislation contains several key tax provisions that affected us, including a reduction of the corporate income tax rate to 21% effective January 1, 2018.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 2818000,
    "operatinglosscarryforwardsexpirationdatedescription": "The available net operating loss carry forwards expire in various years through 2041. No tax benefit has been reported in the financial statements because the Company believes there is a 50% or greater chance the carry forwards will expire unused.",
    "deferredtaxassetsoperatinglosscarryforwards": 677977,
    "deferredtaxassetsvaluationallowance": 677977,
    "effectiveincometaxratecontinuingoperations": 0.24,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.03,
    "increasedecreaseinnetoperatinglossbenefit": -113004,
    "increasedecreaseinvaluationallowance": 113004
  },
  {
    "date": "2020-06-29",
    "symbol": "NXEN",
    "period": "FY",
    "entityregistrantname": "NEXIEN BIOPHARMA, INC.",
    "entitycentralindexkey": 1625288,
    "documenttype": "10-K",
    "documentperiodenddate": "2020-06-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "cashandcashequivalentsatcarryingvalue": 10786,
    "otherassetscurrent": 12000,
    "assetscurrent": 22786,
    "assets": 22786,
    "accountspayableandaccruedliabilitiescurrent": 17151,
    "convertiblenotespayablecurrent": 12000,
    "liabilitiescurrent": 29151,
    "commonstockvalue": 5398,
    "additionalpaidincapital": 11583159,
    "commonstocksubjecttoforfeiture": -3147763,
    "retainedearningsaccumulateddeficit": -8447159,
    "stockholdersequity": -8447159,
    "liabilitiesandstockholdersequity": 22786,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 53984004,
    "commonstocksharesoutstanding": 53984004,
    "professionalfees": 50531,
    "generalandadministrativeexpense": 2495386,
    "impairmentofintangibleassetsfinitelived": 35000,
    "managementfeeexpense": 90667,
    "operatingexpenses": 2671584,
    "interestexpense": 33,
    "othernonoperatingincomeexpense": -33,
    "netincomeloss": -2671617,
    "earningspersharebasicanddiluted": -0.05,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 53912852,
    "sharesoutstanding": 53984004,
    "stockissuedduringperiodvaluesharebasedcompensationforfeited": 18750,
    "fairvalueofoptionsandwarrantsissuedforservices": 33387,
    "issuanceofstockforaccountspayableatsharevalue": 1499,
    "issuanceofstockforaccountspayableshare": 16667,
    "stockissuedduringperiodvalueforlicense": 34962,
    "stockissuedduringperiodsharesissuedforlicense": 381619,
    "stockissuedduringperiodvalueissuedforservices": 1500,
    "stockissuedduringperiodsharesissuedforservices": 16667,
    "amortizationofacquisitioncosts": 2303195,
    "sharesissuedpricepershare": 0.092,
    "sharebasedcompensation": 52137,
    "fairvalueofsharesissuedforacquisition": -2303195,
    "issuanceofstockandwarrantsforservicesorclaims": 42500,
    "increasedecreaseinprepaidexpense": -61647,
    "increasedecreaseinaccountspayableandaccruedliabilities": -26099,
    "netcashprovidedbyusedinoperatingactivities": -147570,
    "paymentstoacquireintangibleassets": 35000,
    "proceedsfromconvertibledebt": 12000,
    "netcashprovidedbyusedinfinancingactivities": 12000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -135570,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 10786,
    "sharesissuedforsettlementofaccountspayable": 1500,
    "operatingincomeloss": 8447159,
    "workingcapitaldeficit": 6365,
    "prepaidinsuranceandother": 12000,
    "prepaidexpensecurrent": 12000,
    "stockissuedduringperiodsharesnewissues": 381619,
    "stockissuedduringperiodvaluenewissues": 78875,
    "legalfees": 94040,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 150000,
    "valueofvestedsharesissuedandamortizationofunvestedshares": 3787237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 18750,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodvalue": 867715,
    "warrantsexercisedshares": 94000,
    "proceedsfromwarrantexercises": 47000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingandexercisablenumber": 2995000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 37500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 0.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageoutstandinandexerciseprice": 0.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingandexcerisableweightedaverageremainingcontractualterm2": "P5Y2M12D",
    "notespayablerelatedpartiescurrentandnoncurrent": 12000,
    "interestpayablecurrentandnoncurrent": 33,
    "equitymethodinvestmentownershippercentage": 1,
    "costsandexpenses": 201228,
    "repaymentsofrelatedpartydebt": 50662,
    "repaymentsofdebt": 90667,
    "debtinstrumentmaturitydate": "2020-03-01",
    "writeoffofremainingbalance": 90667,
    "incometaxexaminationdescription": "On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted into law and the new legislation contains several key tax provisions that affected us, including a reduction of the corporate income tax rate to 21% effective January 1, 2018.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 2348000,
    "operatinglosscarryforwardsexpirationdatedescription": "The available net operating loss carry forwards expire in various years through 2040",
    "deferredtaxassetsoperatinglosscarryforwards": 564973,
    "deferredtaxassetsvaluationallowance": 564973,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.03,
    "increasedecreaseinnetoperatinglossbenefit": -94745,
    "increasedecreaseinvaluationallowance": 94745
  },
  {
    "date": "2019-06-29",
    "symbol": "NXEN",
    "period": "FY",
    "entityregistrantname": "NEXIEN BIOPHARMA, INC.",
    "entitycentralindexkey": 1625288,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-06-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "cashandcashequivalentsatcarryingvalue": 146356,
    "prepaidexpenserelatedpartycurrent": 99667,
    "otherassetscurrent": 64647,
    "duefromrelatedpartiescurrent": 99667,
    "assetscurrent": 310670,
    "assets": 310670,
    "accountspayableandaccruedliabilitiescurrent": 44750,
    "liabilitiescurrent": 44750,
    "commonstockvalue": 5351,
    "additionalpaidincapital": 11505819,
    "commonstocksubjecttoforfeiture": -5469708,
    "retainedearningsaccumulateddeficit": -5775542,
    "stockholdersequity": -5775542,
    "liabilitiesandstockholdersequity": 310670,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 53510718,
    "commonstocksharesoutstanding": 53510718,
    "professionalfees": 200299,
    "researchanddevelopmentexpense": 63858,
    "generalandadministrativeexpense": 3668841,
    "impairmentofintangibleassetsfinitelived": 367915,
    "operatingexpenses": 4300913,
    "netincomeloss": -4300913,
    "earningspersharebasicanddiluted": -0.08,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 51033855,
    "sharesoutstanding": 53510718,
    "vestingofmanagementsharessubjecttoforfeiture": 210418,
    "stockissuedduringperiodvalueacquisitions": -7524000,
    "stockissuedduringperiodsharesacquisitions": 11000000,
    "cancellationofunvestedsharesvalue": 1316700,
    "cancellationofunvestedshares": -1732500,
    "cancellationofvestedsharesvalue": -108286,
    "cancellationofvestedshares": -142500,
    "issuanceofstockforaccountspayableatsharevalue": 1499,
    "issuanceofstockforaccountspayableshare": 15000,
    "stockrepurchasedduringperiodvalue": 8,
    "stockrepurchasedduringperiodshares": -77778,
    "amortizationofacquisitioncosts": 756342,
    "fairvalueofoptionsandwarrantsissuedforservices": 1531403,
    "fairvalueadjustmentofwarrants": 4467,
    "sharesissuedpricepershare": 0.1,
    "sharebasedcompensation": 1897755,
    "fairvalueofsharesissuedforacquistion": -1484042,
    "increasedecreaseinprepaidexpense": 64647,
    "increasedecreaseinduefromrelatedparties": -15000,
    "increasedecreaseinaccountspayable": -42535,
    "netcashprovidedbyusedinoperatingactivities": -643383,
    "paymentstoacquireintangibleassets": 35000,
    "netcashprovidedbyusedininvestingactivities": -30000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -673383,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 146356,
    "sharesissuedforsettlementofaccountspayable": 1500,
    "cancellationofshares": 181,
    "workingcapital": 265920,
    "prepaidinsuranceandother": 64647,
    "prepaidexpensecurrent": 164314,
    "stockissuedduringperiodsharesnewissues": 150000,
    "stockissuedduringperiodvaluenewissues": 18750,
    "legalfees": 94040,
    "capitalizedcostofintangibleassets": 65000,
    "impairmentofintangibleassetsexcludinggoodwill": 367915,
    "stockissuedduringperiodsharesforsettlementofaccountspayable": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 5083333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 635417,
    "fairvalueofreturnedsharescreditedtooperations": 108300,
    "valueofvestedsharesissuedandamortizationofunvestedshares": 1484042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeited": 18750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodvalue": 867715,
    "amortizationofvestedoption": 727406,
    "unamortizationofvestedoption": 66254,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 1038400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 2072800,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexercisepricegranted": 1.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsweightedaverageexercisepriceexpired": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsoutstandingweightedaverageremainingcontractualtermsbeginningbalance": "P1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsoutstandingweightedaverageremainingcontractualtermsendingbalance": "P0Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3032500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3260000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 227500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2895000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y2M12D",
    "equitymethodinvestmentownershippercentage": 1,
    "costsandexpenses": 201228,
    "repaymentsofrelatedpartydebt": 15000,
    "repaymentsofdebt": 1500,
    "debtinstrumentmaturitydate": "2020-03-01",
    "incometaxexaminationdescription": "On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted into law and the new legislation contains several key tax provisions that affected us, including a reduction of the corporate income tax rate to 21% effective January 1, 2018.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 1954000,
    "operatinglosscarryforwardsexpirationdatedescription": "The available net operating loss carry forwards expire in various years through 2039.",
    "deferredtaxassetsoperatinglosscarryforwards": 470228,
    "deferredtaxassetsvaluationallowance": 470228,
    "increasedecreaseinnetoperatinglossbenefit": 161491,
    "increasedecreaseinvaluationallowance": -161491
  }
]